The EMA has recommended extensions to the marketing authorizations for Adcetris, used to treat Hodgkin lymphoma, and ...

The company removed experimental drugs for Alzheimer’s, migraine and pain from its pipeline to focus more resources on “core ...

The screen program is part of the World Economic Forum's EDISON alliance 1 billion lives challenge and through the test, the ...

AstraZeneca partnered with Qure.ai to leverage its technology for assessing chest X-rays and determining potential lung ...

Like many FTSE 100 stocks, this one has been through the mill in 2025. However, it hasn’t recovered, potentially offering ...

Investor AB maintains low leverage, with a net debt of ~SEK 9.5 billion and a conservative long-term approach. Read why I ...

AstraZeneca’s share price has fallen a long way this year, which could mean a bargain to be had, so I ran the key numbers to check if this is the case.

New technology using artificial intelligence conducted 5 million chest X-rays in over 20 countries, helping spot early signs ...

A clinical trial is underway to assess the effectiveness and safety of sipavibart, AstraZeneca's long-acting monoclonal antibody designed to provide protection against Covid-19, as a potential ...

Harvey Jones says the GSK share price has dramatically underperformed FTSE 100 rival AstraZeneca, which has had a stellar run ...

Targeted Oncology provides news, videos, and reviews on the rapidly evolving world of targeted therapies and immunotherapy ...

The pharma industry’s reputation dropped slightly again among patient groups, largely due to drug pricing issues.